Scientists Turn Gut Bacteria Into Pancreatic Cancer Fighters
Reported byUniversity of Chicago Medical Center ↗·Sourced by Goodlede
Researchers engineered Bifidobacterium longum bacteria to deliver an immune signal (SumIL-2) directly into pancreatic tumors, slowing tumor growth in animal models and showing stronger effects when combined with existing therapies like chemotherapy, radiation, and immunotherapy.
The therapy has been tested in animal models; clinical translation in humans remains ahead.
Goodlede runs a two-pass source check on every story: one pass finds it, a second skeptical pass re-verifies the claim and writes what it doesn’t prove. This is a source check, not an independent fact-check — confirm anything important at the link above.
Read the full story at University of Chicago Medical Center
Read original story ↗More good news, verified daily.
Goodlede covers positive developments across science, nature, rights, and human achievement — verified before they appear. No hype, no roundups, no PR wires.
© 2026 Wag Media, LLC
More from Goodlede
Science
Scientist's lifelong obsession with mystery of elusive 'pink zebra' seaweed
BBC · Verified
Arts
The Iconic Watts Towers in Los Angeles Will Get a $22 Million Campus Expansion Ahead of the 2028 Summer Olympics
Smithsonian Smart News · Verified
Science
Study Reveals Thousands of Previously Undocumented Species in Ecuador's Chocó
Rainforest Trust · Verified